Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | KCNN4 | O15554 | 7/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6174190 | 0.98 | MAPT (0.95) | MAPTKMT2AKCNN4CYP2C19HIF1A | |
| SCHEMBL31196684 | 0.87 | MAPT (0.77) | MAPTKMT2AKCNN4CYP2C19HIF1A | |
| SCHEMBL5936056 | 0.81 | MAPT (0.68) | MAPTKMT2AHIF1AHDAC1HTT | |
| SCHEMBL29159698 | 0.81 | MAPT (0.68) | MAPTKMT2AKCNN4CYP2C19HIF1A | |
| SCHEMBL2781433 | 0.81 | MAPT (0.68) | MAPTKMT2AKCNN4CYP2C19HIF1A | |
| SCHEMBL3637376 | 0.80 | KMT2A (0.67) | MAPTKMT2ACYP1A2ALDH1A1TSHR | |
| SCHEMBL25049822 | 0.80 | MAPT (0.67) | MAPTKMT2AKCNN4CYP2C19HIF1A | |
| SCHEMBL6571 | 0.80 | MAPT (0.67) | MAPTKMT2AKCNN4CYP2C19HIF1A | |
| SCHEMBL1706266 | 0.79 | MAPT (0.65) | MAPTKMT2AKCNN4CYP2C19HIF1A | |
| SCHEMBL7873851 | 0.79 | MAPT (0.65) | MAPTKMT2AKCNN4HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384016-A1 | ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE | Bayer Aktiengesellschaft (DE) | 2024-06-19 | — | — | EP | claimed |
| WO-2023017120-A1 | ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE | BAYER AKTIENGESELLSCHAFT (DE) | 2023-02-16 | — | — | WO | claimed |
| CN-104557599-B | Preparation and splitting method of 2-acyl amino-3-biphenylylpropionic acid | 浙江九洲药业股份有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-105399666-A | Fungicide hydroxyimino-heterocyclic derivatives | BAYER CROSPSCIENCE AG | 2016-03-16 | — | — | CN | claimed |
| CN-103781780-B | As the heterocyclyl pyrimidines analogue of JAK inhibitor | CELLZOME LTD. (GB) | 2015-11-25 | — | — | CN | claimed |
| CN-102725270-B | Fungicide hydroxyimino-heterocyclic derivatives | BAYER CROPSCIENCE AG (DE) | 2015-10-07 | — | — | CN | claimed |
| CN-103781780-A | Heterocyclyl pyrimidine analogues as JAK inhibitors | CELLZOME LTD | 2014-05-07 | — | — | CN | claimed |
| US-8703990-B2 | Process for manufacture and resolution of 2-acylamino-3-diphenylpropanoic acid | Zhejiang Jiuzhous Pharmaceutical Co., Ltd. (CN) | 2014-04-22 | — | — | US | claimed |
| CN-102725270-A | Fungicide hydroxyimino-heterocyclic derivatives | BAYER CROPSCIENCE AG | 2012-10-10 | — | — | CN | claimed |
| EP-2261207-A1 | Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives | Aventisub II Inc. (US) | 2010-12-15 | — | — | EP | claimed |
| US-20020007085-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | MERRELL PHARMACEUTICALS INC. | 2002-01-17 | — | — | US | claimed |
| US-20010031895-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | MERRELL DOW PHARMACEUTICALS INC. | 2001-10-18 | — | — | US | claimed |
| US-20010021791-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | MERRELL PHARMACEUTICALS INC. | 2001-09-13 | — | — | US | claimed |
| US-20010020114-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | MERRELL PHARMACEUTICALS INC. | 2001-09-06 | — | — | US | claimed |
| US-20010018521-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | MERRELL PHARMACEUTICALS INC. | 2001-08-30 | — | — | US | claimed |
| US-6242606-B1 | REACTING A A,A-DIMETHYLPHENYLACETIC ACID AMIDE WITH A W-HALO COMPOUND PRODUCES W'-HALO-A-KETO-A,A-DIMETHYLPHENYLACETIC ACID AMIDE AND REACTING IT WITH A PIPERIDINE COMPOUND; 2-(4-(4-CHLORO-BUTYRYL)-PHENYL)-2-METHY-PROPIONIC ACID | MERRELL PHARMACEUTICALS INC. | 2001-06-05 | — | — | US | claimed |
| US-20010000038-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | CHATTEM INC. | 2001-03-15 | — | — | US | claimed |
| JP-H08512028-A | — | — | 1996-12-17 | — | — | JP | claimed |
| EP-0705245-A1 | NOVEL INTERMEDIATES FOR THE PREPARATION OF ANTIHISTAMINIC 4-DIPHENYLMETHYL/DIPHENYLMETHOXY PIPERIDINE DERIVATIVES | MERRELL PHARMACEUTICALS INC. (US) | 1996-04-10 | — | — | EP | claimed |
| WO-1995000480-A1 | NOVEL INTERMEDIATES FOR THE PREPARATION OF ANTIHISTAMINIC 4-DIPHENYLMETHYL/DIPHENYLMETHOXY PIPERIDINE DERIVATIVES | MERRELL PHARMACEUTICALS INC. (US) | 1995-01-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010000038-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | HRH1, HRH3, HRH4 | MAPT 4683/4885KMT2A 1588/4885KCNN4 390/4885 |
| US-20010020114-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | HRH1, HRH3, HRH4 | MAPT 4467/4885KMT2A 2070/4885KCNN4 842/4885 |
| US-20010021791-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | HRH1, HRH3, HRH4 | MAPT 4700/4885KMT2A 2014/4885KCNN4 656/4885 |
| US-20010031895-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | HRH1, HRH4, HRH3 | MAPT 4723/4885KMT2A 2187/4885KCNN4 730/4885 |
| US-20010018521-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | HRH1, HRH3, HRH4 | MAPT 4664/4885KMT2A 2055/4885KCNN4 530/4885 |
| US-20020007085-A1 | Novel intermediates useful for the preparation of antihistaminic piperidine derivatives | HRH1, HRH3, HRH4 | MAPT 4724/4885KMT2A 2217/4885KCNN4 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.